Product Information
LOPERAMIDE 2 MG CAPSULE is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $0.0541 per EA under NDC 00378210001. Its NADAC has been published 657 times since Nov 28, 2013.
Strength
2 mg/1
Manufacturer
Mylan Pharmaceuticals Inc.NDC
00378210001
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
LOPERAMIDE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA072741On Market Since
9/18/1991
Pharmacological Classes
Price Statistics
The NADAC for LOPERAMIDE 2 MG CAPSULE has been published 657 times since Nov 28, 2013, and over the history we have for it it has declined 59.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0541 per EA |
|---|---|
| All-time high | $0.3427 (Feb 10, 2016) |
| All-time low | $0.0520 (Feb 18, 2026) |
| 52-week high | $0.1160 |
| 52-week low | $0.0520 |
| Median price | $0.2788 |
| Average price | $0.2396 |
| Largest weekly change | +44.3% (Aug 21, 2024) |
| Weeks tracked | 657 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 4 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 4 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of LOPERAMIDE 2 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for LOPERAMIDE 2 MG CAPSULE, manufactured by Mylan Pharmaceuticals Inc., is $0.0541 per EA (NDC 00378210001), effective Jun 24, 2026.
How has the price of LOPERAMIDE 2 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for LOPERAMIDE 2 MG CAPSULE has declined 59.7%. It has been tracked across 657 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for LOPERAMIDE 2 MG CAPSULE?
Since Nov 28, 2013, the NADAC for LOPERAMIDE 2 MG CAPSULE has ranged from a low of $0.0520 (Feb 18, 2026) to a high of $0.3427 (Feb 10, 2016), with a median of $0.2788 per EA.
Are there cheaper alternatives to LOPERAMIDE 2 MG CAPSULE?
4 NADAC-published products share the same active ingredient, strength, and dosage form as LOPERAMIDE 2 MG CAPSULE, but none are currently priced below it.
Who manufactures LOPERAMIDE 2 MG CAPSULE?
LOPERAMIDE 2 MG CAPSULE (NDC 00378210001) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification